Cargando…
Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677817/ https://www.ncbi.nlm.nih.gov/pubmed/36420259 http://dx.doi.org/10.3389/fimmu.2022.1074864 |
| _version_ | 1784833872302702592 |
|---|---|
| author | Wu, Jianping Wei, Xiaona Li, Jiajia Gan, Yangang Zhang, Rui Han, Qianqian Liang, Peifen Zeng, Yuchun Yang, Qiongqiong |
| author_facet | Wu, Jianping Wei, Xiaona Li, Jiajia Gan, Yangang Zhang, Rui Han, Qianqian Liang, Peifen Zeng, Yuchun Yang, Qiongqiong |
| author_sort | Wu, Jianping |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9677817 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96778172022-11-22 Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy Wu, Jianping Wei, Xiaona Li, Jiajia Gan, Yangang Zhang, Rui Han, Qianqian Liang, Peifen Zeng, Yuchun Yang, Qiongqiong Front Immunol Immunology Frontiers Media S.A. 2022-11-07 /pmc/articles/PMC9677817/ /pubmed/36420259 http://dx.doi.org/10.3389/fimmu.2022.1074864 Text en Copyright © 2022 Wu, Wei, Li, Gan, Zhang, Han, Liang, Zeng and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Immunology Wu, Jianping Wei, Xiaona Li, Jiajia Gan, Yangang Zhang, Rui Han, Qianqian Liang, Peifen Zeng, Yuchun Yang, Qiongqiong Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy |
| title | Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy |
| title_full | Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy |
| title_fullStr | Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy |
| title_full_unstemmed | Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy |
| title_short | Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy |
| title_sort | corrigendum: plasma exosomal irak1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with iga nephropathy |
| topic | Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677817/ https://www.ncbi.nlm.nih.gov/pubmed/36420259 http://dx.doi.org/10.3389/fimmu.2022.1074864 |
| work_keys_str_mv | AT wujianping corrigendumplasmaexosomalirak1canbeapotentialbiomarkerforpredictingthetreatmentresponsetoreninangiotensinsysteminhibitorsinpatientswithiganephropathy AT weixiaona corrigendumplasmaexosomalirak1canbeapotentialbiomarkerforpredictingthetreatmentresponsetoreninangiotensinsysteminhibitorsinpatientswithiganephropathy AT lijiajia corrigendumplasmaexosomalirak1canbeapotentialbiomarkerforpredictingthetreatmentresponsetoreninangiotensinsysteminhibitorsinpatientswithiganephropathy AT ganyangang corrigendumplasmaexosomalirak1canbeapotentialbiomarkerforpredictingthetreatmentresponsetoreninangiotensinsysteminhibitorsinpatientswithiganephropathy AT zhangrui corrigendumplasmaexosomalirak1canbeapotentialbiomarkerforpredictingthetreatmentresponsetoreninangiotensinsysteminhibitorsinpatientswithiganephropathy AT hanqianqian corrigendumplasmaexosomalirak1canbeapotentialbiomarkerforpredictingthetreatmentresponsetoreninangiotensinsysteminhibitorsinpatientswithiganephropathy AT liangpeifen corrigendumplasmaexosomalirak1canbeapotentialbiomarkerforpredictingthetreatmentresponsetoreninangiotensinsysteminhibitorsinpatientswithiganephropathy AT zengyuchun corrigendumplasmaexosomalirak1canbeapotentialbiomarkerforpredictingthetreatmentresponsetoreninangiotensinsysteminhibitorsinpatientswithiganephropathy AT yangqiongqiong corrigendumplasmaexosomalirak1canbeapotentialbiomarkerforpredictingthetreatmentresponsetoreninangiotensinsysteminhibitorsinpatientswithiganephropathy |